You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 3, July 21, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Critical Care/ Intensive Care Medicine
 •Critical Care Medicine, Other
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Inhaled Nitric Oxide in Acute Lung Injury—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: In response to Dr Kaisers and colleagues, there had been only 2 other large published studies of inhaled nitric oxide in patients with ARDS.1-2 The first of these studies was halted early. It enrolled only patients who increased their oxygenation status when challenged with inhaled nitric oxide prior to enrollment. In that trial, the number of patients with improved signs of acute lung injury was not statistically different between the 2 treatment groups, the primary end point of the trial. The design of our 2 trials was different in that all patients were randomized and response status was not established. Our first study was a phase 2 study that was designed to ascertain safety and potentially link a dose effect to clinical outcome in patients with ARDS. A post-hoc analysis suggested that there was a clinical benefit of inhaled nitric oxide at 5 ppm among this group of . . . [Full Text of this Article]

R. Phillip Dellinger, MD
dellinger-phil@cooperhealth.edu
Robert Wood Johnson Medical College/UMDNJ
Cooper University Hospital
Camden, NJ

Robert W. Taylor, MD
St Louis University
St John's Mercy Medical Center
St Louis, Mo

Janice L. Zimmerman, MD
Baylor College of Medicine
Ben Taub General Hospital
Houston, Tex

Richard C. Straube, MD
INO Therapeutics Inc
Clinton, NJ
For the Inhaled Nitric Oxide in ARDS Study Group



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Inhaled Nitric Oxide in Acute Lung Injury
Udo Kaisers, Maria Deja, Willehad Boemke, and Thilo Busch
JAMA. 2004;292(3):327.
EXTRACT | FULL TEXT  

Low-Dose Inhaled Nitric Oxide in Patients With Acute Lung Injury: A Randomized Controlled Trial
Robert W. Taylor, Janice L. Zimmerman, R. Phillip Dellinger, Richard C. Straube, Gerard J. Criner, Kenneth Davis, Jr, Kathleen M. Kelly, Thomas C. Smith, and Robert J. Small
JAMA. 2004;291(13):1603-1609.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.